Financial Review: Labcorp (NYSE:LH) and AirSculpt Technologies (NASDAQ:AIRS)

AirSculpt Technologies (NASDAQ:AIRS) and Labcorp (NYSE:LH) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings.

Risk and Volatility

AirSculpt Technologies has a beta of 2.25, meaning that its stock price is 125% more volatile than the S&P 500. Comparatively, Labcorp has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent recommendations and price targets for AirSculpt Technologies and Labcorp, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AirSculpt Technologies	1	1	0	0	1.50
Labcorp	0	3	9	0	2.75

AirSculpt Technologies presently has a consensus price target of $4.50, suggesting a potential upside of 87.50%. Labcorp has a consensus price target of $330.00, suggesting a potential upside of 7.22%. Given AirSculpt Technologies’ higher probable upside, equities analysts clearly believe AirSculpt Technologies is more favorable than Labcorp.

Earnings and Valuation

This table compares AirSculpt Technologies and Labcorp”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AirSculpt Technologies	$151.82 million	1.14	-$11.67 million	($0.18)	-13.33
Labcorp	$13.95 billion	1.79	$876.50 million	$12.09	25.46

Labcorp has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares AirSculpt Technologies and Labcorp’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AirSculpt Technologies	-7.79%	-5.83%	-2.88%
Labcorp	6.99%	16.74%	7.81%

Institutional and Insider Ownership

91.5% of AirSculpt Technologies shares are held by institutional investors. Comparatively, 95.9% of Labcorp shares are held by institutional investors. 44.6% of AirSculpt Technologies shares are held by insiders. Comparatively, 0.8% of Labcorp shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Labcorp beats AirSculpt Technologies on 11 of the 14 factors compared between the two stocks.

About AirSculpt Technologies

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas. The company’s body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

About Labcorp

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.